Lv1
50 积分 2026-01-09 加入
Inhibitory Effects of Etidronate on the Progression of Vascular Calcification in Hemodialysis Patients
1个月前
已完结
Acute effects of cinacalcet on arterial stiffness and ventricular function in hemodialysis patients: A randomized double-blinded crossover study
1个月前
已完结
SHR6508, a Calcium-Sensing Receptor Agonist, in Patients on Hemodialysis Who Have Secondary Hyperparathyroidism: A Phase 2 Trial
1个月前
已关闭
Simultaneous Control of PTH and Ca×P Is Sustained over Three Years of Treatment with Cinacalcet HCl
1个月前
已完结
A Single- and Multiple-Dose, Multicenter Study of Etelcalcetide in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism
1个月前
已完结
An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism
1个月前
已完结
Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives
1个月前
已完结
264 The Phase 3 Program of Upacicalcet/PLS240 for the Treatment Of Secondary Hyperparathyroidism in Patients on Hemodialysis
1个月前
已完结
Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients
1个月前
已完结
Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-controlled, dose-finding study
1个月前
已完结
皖公网安备34019202002308
